Cargando…

Association Between First Episode Schizophrenia, Metabolic Syndrome and Insulin Resistance-Related Proteins in Female Balb/C Mice

BACKGROUND: Metabolic syndrome is a group of different disorders mainly includes, insulin resistance, obesity, cerebrovascular disorders, dyslipidemia, which leads to increase mortality. Patients suffering from related psychotic disorders such as schizophrenia are at the higher risk of developing me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sattar, Haseeb, Li, Huqun, Han, Yong, Zhou, Hong, Darbalaei, Sanaz, Li, Weiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Salvia Medical Sciences Ltd 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343899/ https://www.ncbi.nlm.nih.gov/pubmed/34466413 http://dx.doi.org/10.22086/gmj.v0i0.692

Ejemplares similares

Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance
por: Li, Huqun, et al.
Publicado: (2016)

Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance
por: Li, Huqun, et al.
Publicado: (2019)

Glucose metabolism, hippocampal subfields and cognition in first-episode and never-treated schizophrenia
por: Xiu, Meihong, et al.
Publicado: (2023)

Treatment Response in First-episode Schizophrenia
por: Schennach, Rebecca, et al.
Publicado: (2012)

The neurobiology and treatment of first-episode schizophrenia
por: Kahn, R S, et al.
Publicado: (2015)

Dysexecutive Behavior in First-Episode Schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2022)

Role of Glucuronidation Pathway in Quetiapine Metabolism: An In vivo Drug–Drug Interaction Study between Quetiapine and Probenecid
por: Sattar, Haseeb, et al.
Publicado: (2020)

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia
por: Tao, Qi, et al.
Publicado: (2020)

Stage-Specific Brain Aging in First-Episode Schizophrenia and Treatment-Resistant Schizophrenia
por: Kim, Woo-Sung, et al.
Publicado: (2022)

APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
por: Liu, Yong, et al.
Publicado: (2019)

Follow-up of N400 in the Rehabilitation of First-episode Schizophrenia
por: Du, Xiang-Dong, et al.
Publicado: (2015)

T233. DEFINING TREATMENT RESPONSE AND RESISTANCE IN FIRST EPISODE SCHIZOPHRENIA
por: Dempster, Kara, et al.
Publicado: (2018)

Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010)

Executive attention impairment in first-episode schizophrenia
por: Orellana, Gricel, et al.
Publicado: (2012)

Sleep quality in first-episode schizophrenia patients
por: Abdellatif, M., et al.
Publicado: (2023)

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients
por: Misiak, Błażej, et al.
Publicado: (2016)

Risk factors for medication-induced amenorrhea in first-episode female Chinese patients with schizophrenia treated with risperidone
por: Chen, Haizhi, et al.
Publicado: (2013)

Altered asymmetries of resting‐state MRI in the left thalamus of first‐episode schizophrenia
por: Liu, Sha, et al.
Publicado: (2022)

Impaired Emotional Self-Referential Processing in First-Episode Schizophrenia
por: Zhao, Yanli, et al.
Publicado: (2021)

Psychopathology and treatment responsiveness of patients with first-episode schizophrenia
por: Češková, Eva, et al.
Publicado: (2005)

Reduced Context Effects on Retrieval in First-Episode Schizophrenia
por: Talamini, Lucia M., et al.
Publicado: (2010)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Gender Difference in the Prodromal Symptoms of First-episode Schizophrenia
por: Choi, Jung-Seok, et al.
Publicado: (2009)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Hippocampal Subfield Volumes in First Episode and Chronic Schizophrenia
por: Kawano, Mitsuhiko, et al.
Publicado: (2015)

Increased Blood-Reelin-Levels in First Episode Schizophrenia
por: Hornig, Tobias, et al.
Publicado: (2015)

Symptoms at Onset in First Episode Schizophrenia: Caregivers Perspectives
por: Tharoor, Hema, et al.
Publicado: (2015)

Dissecting the Heterogeneity of Treatment Response in First-Episode Schizophrenia
por: Malhotra, Anil K.
Publicado: (2015)

31. OPTIMISE-ING THE TREATMENT OF FIRST-EPISODE SCHIZOPHRENIA
por: Arango, Celso
Publicado: (2018)

Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia
por: Beyazyüz, Murat, et al.
Publicado: (2014)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

Abnormal patterns of regional homogeneity and functional connectivity across the adolescent first-episode, adult first-episode and adult chronic schizophrenia
por: Yang, Yongfeng, et al.
Publicado: (2022)

Metabolism and pharmacokinetics of a novel polyphenol fatty acid ester phloridzin docosahexaenoate in Balb/c female mice
por: Fernando, Wasundara, et al.
Publicado: (2020)

Changes in event-related potentials in patients with first-episode schizophrenia and their siblings
por: Yang, Chengqing, et al.
Publicado: (2017)

Impact of childhood trauma on sensory gating in patients with first-episode schizophrenia
por: Li, Xian-Bin, et al.
Publicado: (2018)

Ameliorative patterns of grey matter in patients with first-episode and treatment-naïve schizophrenia
por: Li, Mingli, et al.
Publicado: (2023)

Depth‐dependent abnormal cortical myelination in first‐episode treatment‐naïve schizophrenia
por: Wei, Wei, et al.
Publicado: (2020)

Controllability of Functional Brain Networks and Its Clinical Significance in First-Episode Schizophrenia
por: Li, Qian, et al.
Publicado: (2022)

Mammary tumors suppress aging-induced neuroinflammation in female Balb/c mice
por: Barrientos, Ruth M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_agj92eobarhvpg4cl5methh6m7